Sam Altman says the singularity is here and will be ‘hugely positive, awesome for the world.’ So what is the singularity, and ...

During the 2016 election, much of the country was introduced to the concept of internet bots for the first time. Now, just a decade later, it feels like they’re everywhere.

A third option is suppression: the United States would forgo development of ASI and stop anyone else from building it on the basis that superintelligence is just too dangerous to be unleashed on the ...

Every night, millions of otherwise intelligent adults open a streaming app containing more television than any human being ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical stage programs, including REC-4881 in FAP, where we have generated some ...

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

Function Health, a company that offers lab testing and body scans for early disease detection, landed $450 million in growth financing to scale its tech-enabled personalized preventive health services ...

Recursion Pharmaceuticals (RXRX) closed at $3.01 in the latest trading session, marking a +1.69% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.02%. Elsewhere, the Dow saw ...

Recursion Pharmaceuticals (RXRX) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.41 per share a year ago. These ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The growth financing follows two ...